S. Nissen

发表

Medical device recalls and the FDA approval process.

D. Zuckerman, Paul Brown, S. Nissen, 2011, Archives of internal medicine.

Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis

Harlan M. Krumholz, Joseph S. Ross, H. Krumholz, 2009, PLoS medicine.

Association of Bariatric Surgery With Cancer Risk and Mortality-Reply.

A. Aminian, S. Nissen, 2022, JAMA.

When Is a Placebo Not a Placebo.

S. Nissen, 2022, JAMA cardiology.

Can we trust observational data for clinical decision-making?

S. Nissen, G. Reed, 2018, European heart journal.

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.

D. Grobbee, P. Thompson, J. Kastelein, 2023, The New England journal of medicine.

Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials

Deepak L. Bhatt, P. Ridker, R. Glynn, 2023, The Lancet.

Representation of Women in Cardiovascular Clinical Trial Leadership.

M. Walsh, J. Silver, L. Cho, 2020, JAMA internal medicine.

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

D. Mozaffarian, P. Ridker, P. Barter, 2020, JAMA.

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

A. Anand, D. Malone, F. Goes, 2023, The New England journal of medicine.

Cardiovascular Safety of Testosterone-Replacement Therapy.

Michael G. Miller, T. Travison, C. Granger, 2023, The New England journal of medicine.

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery

S. Ellis, A. Lincoff, S. Nissen, 2017, Journal of the American Heart Association.

-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials

E. Tuzcu, P. Schoenhagen, M. Shishehbor, 2007, Annals of Internal Medicine.

In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis.

E. Topol, M. Lauer, A. Lincoff, 2003, Archives of internal medicine.

Impact of statins on serial coronary calcification during atheroma progression and regression.

Yu Kataoka, Rishi Puri, M. Shao, 2015, Journal of the American College of Cardiology.

Intravascular ultrasound of the coronary arteries: current applications and future directions.

S E Nissen, A. DeMaria, S. Nissen, 1992, The American journal of cardiology.

Comparative Effectiveness of Diabetes Drugs: The Use and Misuse of Observational Research

S. Nissen, 2023, Annals of Internal Medicine.

ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions.

J. Murray, D. F. Leon, R. Gibbons, 1999, Journal of the American College of Cardiology.

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

A. Lincoff, S. Nissen, S. Nicholls, 2007, JAMA.

American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

C. Tracy, P. Fitzgerald, P. Yock, 2001, Journal of the American College of Cardiology.

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.

Paul Schoenhagen, Taro Tsunoda, Tim Crowe, 2003, JAMA.

Risk of cardiovascular events associated with selective COX-2 inhibitors.

E. Topol, S. Nissen, D. Mukherjee, 2001, JAMA.

The current status of intravascular ultrasound imaging.

E. Tuzcu, S. Kapadia, S. Nissen, 1999, Current problems in cardiology.

Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments.

J. Koyama, S. Nakatani, S. Nissen, 1994, Journal of the American College of Cardiology.

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Ming-Dauh Wang, M. Shao, J. Kastelein, 2011, JAMA.

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.

E. Tuzcu, J. Saw, Alfonso T. Perez, 2008, JAMA.

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial

P. Libby, D. Graham, H. Krum, 2017, European heart journal.

Extent and direction of arterial remodeling in stable versus unstable coronary syndromes : an intravascular ultrasound study.

S E Nissen, E. Tuzcu, P. Schoenhagen, 2000, Circulation.

Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis.

D G Vince, S E Nissen, E. Tuzcu, 2001, Journal of the American College of Cardiology.

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.

P. Libby, D. Graham, H. Krum, 2009, American heart journal.

Intravascular ultrasound: novel pathophysiological insights and current clinical applications.

P. Yock, S. Nissen, S. Nissen, 2001, Circulation.

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease.

David P Miller, E. Topol, M. Kutner, 1995, Circulation.

Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.

E. Topol, S. Nissen, S. Nissen, 1995, Circulation.

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

Paul Schoenhagen, Milind Y Desai, Stanley L Hazen, 2007, JAMA.

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Paul Schoenhagen, Tim Crowe, C. Grines, 2004, JAMA.

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials

R. Collins, B. Davis, S. Yusuf, 2015, The Lancet.

Effect of two intensive statin regimens on progression of coronary disease.

Peter Libby, P. Libby, R. Erbel, 2011, The New England journal of medicine.

Effect of torcetrapib on the progression of coronary atherosclerosis.

Jean-Claude Tardif, E. Tuzcu, J. Tardif, 2007, The New England journal of medicine.

Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis

E. Tuzcu, S. Kapadia, S. Nissen, 2015, European journal of preventive cardiology.

Atheroma Progression in Hyporesponders to Statin Therapy

J. S. St. John, E. Tuzcu, S. Nissen, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial

P. Libby, E. Topol, E. Tuzcu, 2004 .

Coronary artery imaging with multidetector computed tomography: a call for an evidence-based, multidisciplinary approach.

Richard D. White, Mario J. Garcia, E. Topol, 2006, American heart journal.

Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis.

E. Tuzcu, P. Schoenhagen, S. Nissen, 2006, Journal of the American College of Cardiology.

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial

J. S. St. John, A. Lincoff, S. Nissen, 2020, BMJ Open Diabetes Research & Care.

Coronary angiography and intravascular ultrasound.

S. Nissen, S. Nissen, S Nissen, 2001, The American journal of cardiology.

High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN

P. Libby, M. Shao, R. Erbel, 2014, Diabetes Care.

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

E. Tuzcu, P. Schoenhagen, S. Nissen, 2005 .

Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients.

H. Brewer, S. Nissen, K. Krueger, 2016, Journal of clinical lipidology.

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial

M. Shao, J. Kastelein, A. Lincoff, 2019, JAMA cardiology.

Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.

M. Shao, E. Tuzcu, S. Kapadia, 2014, The American journal of cardiology.

Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging.

E. Tuzcu, S. Kapadia, V. Guetta, 1998, Circulation.

Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis

E. Tuzcu, D. Vince, P. Schoenhagen, 2002, Circulation.

Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease.

J David Spence, Y. Arad, C. Ballantyne, 2002, The American journal of cardiology.

ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies

P. Barter, J. Kastelein, C. Ballantyne, 2012, Cardiovascular Drugs and Therapy.

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.

P. Libby, P. Ridker, J. Kastelein, 2023, JAMA.

Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging.

E. Tuzcu, P. McCarthy, S. Nissen, 1996, Journal of the American College of Cardiology.

Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance.

P. Libby, D. Grobbee, P. Thompson, 2020, American heart journal.

Intracoronary ultrasound examinations reveal significantly more advanced coronary atherosclerosis in people with type 1 diabetes than in age- and sex-matched non-diabetic controls

E. Tuzcu, P. Schoenhagen, S. Nissen, 2007, Diabetes & vascular disease research.

Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.

Stephen J. Nicholls, Steven E. Nissen, E. Murat Tuzcu, 2010, Journal of the American College of Cardiology.

Warfarin Use Is Associated With Progressive Coronary Arterial Calcification: Insights From Serial Intravascular Ultrasound.

M. Shao, E. Tuzcu, S. Kapadia, 2017, JACC. Cardiovascular imaging.

Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2006, Journal of the American College of Cardiology.

Noninvasive imaging of coronary arteries: current and future role of multi-detector row CT.

Richard D. White, Paul Schoenhagen, Richard D White, 2004, Radiology.

Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials.

E. Tuzcu, P. Schoenhagen, S. Nissen, 2008, Journal of the American College of Cardiology.

Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis.

E. Tuzcu, James D. Thomas, U. Khot, 2003, The New England journal of medicine.

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

Akshay S. Desai, M. Landray, D. DeMets, 2018, Journal of the American College of Cardiology.

The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound.

Ellis, S E Nissen, E. Tuzcu, 1996, Journal of the American College of Cardiology.

Potential Bias About the Association Between Weight Loss Surgery and COVID-19 Infection-Reply.

A. Aminian, S. Nissen, 2022, JAMA surgery.

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

P. Libby, D. Graham, F. Ruschitzka, 2016, The New England journal of medicine.

Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis: Insights From ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation)

E. Tuzcu, J. Tardif, S. Nissen, 2008, Circulation.

Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: importance of vessel size in predicting long-term freedom from target vessel revascularization.

E. Tuzcu, S. Ellis, S. Kapadia, 2001, American heart journal.

Value and limitations of computer analysis of digital subtraction angiography in the assessment of coronary flow reserve.

J. Elion, A. DeMaria, S. Nissen, 1986, Circulation.

Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.

Paul Schoenhagen, M. Shao, E. Tuzcu, 2010, Journal of the American College of Cardiology.

Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2009, Journal of the American College of Cardiology.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

J. Kastelein, J. Jukema, W. Koenig, 2014, JAMA.

Surrogate markers for atherosclerotic disease

D. Pennell, P. Schoenhagen, J. Jukema, 2005, Current opinion in lipidology.

Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.

E. Tuzcu, S. Nissen, S. Nicholls, 2012, Journal of the American College of Cardiology.

Application of a new phased-array ultrasound imaging catheter in the assessment of vascular dimensions. In vivo comparison to cineangiography.

C. Grines, A. DeMaria, S. Nissen, 1990, Circulation.

Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound.

E. Tuzcu, S. Hazen, P. Schoenhagen, 2006, Journal of the American College of Cardiology.

Left main coronary atherosclerosis progression, constrictive remodeling, and clinical events.

E. Tuzcu, S. Kapadia, S. Nissen, 2013, JACC. Cardiovascular interventions.

Effect of Pregnancy on Liver Tumor Associated With Oral Contraceptives

S. Nissen, S. Nissen, D. Ziehm, 1978, Obstetrics and gynecology.

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial

P. Barter, J. Kastelein, C. Ballantyne, 2016, American Journal of Cardiovascular Drugs.

Automated three-dimensional assessment of coronary artery anatomy with intravascular ultrasound scanning.

Azita Tajaddini, Paul Schoenhagen, Jon D Klingensmith, 2003, American heart journal.

Intravascular ultrasound: novel pathophysiological insights and current clinical applications.

P. Yock, S. Nissen, 2001, Circulation.

Intravascular ultrasound evidence of ostial narrowing in nonatherosclerotic left main coronary arteries.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2002, The American journal of cardiology.

Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.

M. Chen, E. Tuzcu, P. Schoenhagen, 2006, Atherosclerosis.

Static and serial assessments of coronary arterial remodeling are discordant: an intravascular ultrasound analysis from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2006, American heart journal.

Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation.

E. Tuzcu, S. Kapadia, P. McCarthy, 2005, Journal of the American College of Cardiology.

Intravascular ultrasound assessment of the prevalence and causes of angiographic "haziness" following high-pressure coronary stenting.

E. Tuzcu, S. Ellis, S. Nissen, 1997, The American journal of cardiology.

Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound.

E. Tuzcu, P. McCarthy, S. Nissen, 1995, Circulation.

Relationship between residual atheroma burden and neointimal growth in patients undergoing stenting: analysis of the atherectomy before MULTI-LINK improves lumen gain and clinical outcomes trial intravascular ultrasound substudy.

E. Tuzcu, P. Schoenhagen, S. Nissen, 2002, Journal of the American College of Cardiology.

High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults: Evidence From Intravascular Ultrasound

Steven E. Nissen, E. Murat Tuzcu, Samir R. Kapadia, 2001, Circulation.

Atherosclerosis regression: Is low-density lipoprotein or high-density lipoprotein the answer?

E. Tuzcu, S. Nissen, S. Nicholls, 2007, Current atherosclerosis reports.

Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study.

W. Peacock, S. Nissen, F. van Lente, 1999, Journal of the American College of Cardiology.

Attenuated plaque at nonculprit lesions in patients enrolled in intravascular ultrasound atherosclerosis progression trials.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2009, JACC. Cardiovascular interventions.

Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions in Patients With Unstable and Stable Presentation

G. Stone, C. Grines, E. Tuzcu, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA:Cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Study.

E. Tuzcu, P. Schoenhagen, S. Nissen, 2006, American heart journal.

Frequency-domain optical coherence tomographic analysis of plaque microstructures at nonculprit narrowings in patients receiving potent statin therapy.

E. Tuzcu, S. Kapadia, S. Nissen, 2014, The American journal of cardiology.

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen.

P. Libby, D. Graham, M. Shao, 2018, Journal of the American College of Cardiology.

Prediction of short- and long-term outcomes by troponin t levels in low-risk patients evaluated for acute coronary syndromes.

W. Peacock, S. Nissen, F. van Lente, 2000, Annals of emergency medicine.

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial

A. Lincoff, S. Nissen, E. McErlean, 2019, Journal of the American Heart Association.

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial.

N. Smedira, M. Desai, H. Schaff, 2023, JAMA cardiology.

Effect of ACAT inhibition on the progression of coronary atherosclerosis.

Carl J Pepine, Paul Schoenhagen, E. Michelson, 2006, The New England journal of medicine.

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial.

D. Rader, P. Barter, A. Tall, 2015, American heart journal.

Gastrointestinal Surgery for Obesity and Diabetes: Weight Loss and Control of Hyperglycemia

P. Schauer, H. Heneghan, S. Nissen, 2012, Current Atherosclerosis Reports.

Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial

S. Kashyap, A. Lincoff, S. Nissen, 2019, Diabetes & vascular disease research.

The painful truth.

S. Nissen, 2010, European heart journal.

Rate of progression of coronary atherosclerotic plaque in women.

E. Tuzcu, S. Hazen, P. Schoenhagen, 2007, Journal of the American College of Cardiology.

Lumen Loss in Transplant Coronary Artery Disease Is a Biphasic Process Involving Early Intimal Thickening and Late Constrictive Remodeling Results From a 5-Year Serial Intravascular Ultrasound Study

Gustavo Rincon, Jon D. Klingensmith, Steven E. Nissen, 2001 .

Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.

J. S. St. John, A. Lincoff, S. Nissen, 2020, JAMA cardiology.

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial.

J. Suico, H. Linnebjerg, G. Ruotolo, 2023, JAMA.

Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome.

E. Tuzcu, Bo Hu, A. Lavoie, 2010, Journal of the American College of Cardiology.

Exploring coronary atherosclerosis with intravascular imaging.

E. Tuzcu, R. Puri, S. Nissen, 2013, International journal of cardiology.

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy

J. S. St. John, A. Lincoff, S. Nissen, 2019, Journal of the American Heart Association.

Coronary Endothelium-Dependent Vasoreactivity and Atheroma Volume in Subjects With Stable, Minimal Angiographic Disease Versus Non–ST-Segment–Elevation Myocardial Infarction: An Intravascular Ultrasound Study

E. Tuzcu, S. Nissen, J. Beltrame, 2013, Circulation. Cardiovascular imaging.

Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruct

E. Tuzcu, Alfonso T. Perez, S. Nissen, 2011, Journal of the American College of Cardiology.

Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.

J. S. St. John, E. Tuzcu, S. Nissen, 2014, The American journal of cardiology.

Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial.

S. Nissen, Stephen J. Nicholls, Kausik K. Ray, 2023, The lancet. Diabetes & endocrinology.

Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2003, Journal of the American College of Cardiology.

Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus

M. Shao, E. Tuzcu, S. Nissen, 2013, European journal of preventive cardiology.

Application of intravascular ultrasound in anti-atherosclerotic drug development

Stephen J. Nicholls, Steven E. Nissen, E. Murat Tuzcu, 2006, Nature reviews. Drug discovery.

The vulnerable coronary plaque.

P. Schoenhagen, S. Nissen, E. McErlean, 2000, The Journal of cardiovascular nursing.

Detection of Vulnerable Coronary Plaque; The Emerging Role of Intravascular Ultrasound

E. Tuzcu, P. Schoenhagen, S. Nissen, 2003 .

Atherosclerotic plaque distribution in the left anterior descending coronary artery as assessed by intravascular ultrasound.

E. Tuzcu, P. Schoenhagen, S. Nissen, 2003, The American journal of cardiology.

ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and

D. F. Leon, D. Faxon, R. Russell, 1999, Circulation.

Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound.

E. Tuzcu, S. Nicholls, R. Puri, 2012, Journal of the American College of Cardiology.

Coronary artery calcification and changes in atheroma burden in response to established medical therapies.

Paul Schoenhagen, Stanley L Hazen, E. Tuzcu, 2007, Journal of the American College of Cardiology.

Sex Differences in Nonculprit Coronary Plaque Microstructures on Frequency-Domain Optical Coherence Tomography in Acute Coronary Syndromes and Stable Coronary Artery Disease

E. Tuzcu, S. Kapadia, S. Nissen, 2016, Circulation. Cardiovascular imaging.

Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling.

E. Tuzcu, D. Vince, P. Schoenhagen, 2002, The American journal of cardiology.

Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2005, The American journal of cardiology.

Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration.

E. Tuzcu, D. Vince, P. Schoenhagen, 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging.

E. Tuzcu, S. Kapadia, S. Nissen, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Coronary angiography for follow-up of heart transplant recipients: insights from TIMI frame count and TIMI myocardial perfusion grade.

E. Tuzcu, S. Kapadia, S. Nissen, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Association of arterial expansion (expansive remodeling) of bifurcation lesions determined by intravascular ultrasonography with unstable clinical presentation.

A. Jeremias, E. Tuzcu, D. Vince, 2001, The American journal of cardiology.

Rationale for a postintervention continuum of care: insights from intravascular ultrasound.

S. Nissen, S. Nissen, 2000, The American journal of cardiology.

Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics.

Deepak L. Bhatt, A. Lincoff, Darren K Mcguire, 2023, American heart journal.

Peripheral arterial disease and progression of coronary atherosclerosis.

E. Tuzcu, P. Schoenhagen, S. Kapadia, 2011, Journal of the American College of Cardiology.

Impact of intravascular ultrasound in understanding transplant coronary artery disease.

E. Tuzcu, S. Kapadia, S. Nissen, 1999, Current opinion in cardiology.

Assessment of coronary compensatory enlargement by three-dimensional intravascular ultrasound

E. Tuzcu, D. Vince, J. Cornhill, 2000, The International Journal of Cardiac Imaging.

Can Nonalcoholic Steatohepatitis Be Surgically Cured?

A. Aminian, J. Bena, N. Alkhouri, 2023, Annals of surgery.

Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study.

E. Tuzcu, S. Kapadia, S. Nissen, 2001, Journal of the American College of Cardiology.